Posted by Michael Wonder on 01 Aug 2018
Free access plan for 'revolutionary' drug that could eliminate Hepatitis C by 2030
1 August 2018 - What has been called a "revolutionary" hepatitis C drug could soon be available free-of-charge to all Kiwis with the chronic form of the infection.
PHARMAC, the Government's drug funding body, has released a proposal to fund direct acting anti-viral drug Maviret for anyone with chronic hepatitis C.
Health workers and patients say moving to make the drug available from October 1 has the potential to all-but eradicate the disease in New Zealand.
